Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Zhiling Yan"'
Autor:
Cheng Zhang, Xiaoqi Wang, Hai Yi, Yi Wang, Zhiling Yan, Jian Zhou, Ting Yang, Aibin Liang, Zhen Wang, Yingying Ma, Qin Wen, Lei Gao, Li Gao, Peiyan Kong, Xu Tan, Erlie Jiang, Xi Zhang
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-4 (2024)
Abstract Chimeric Antigen Receptor T (CAR-T) cell therapy has significantly advanced in treating B-cell acute lymphoblastic leukemia (B-ALL) and has shown efficacy in managing relapsed B-ALL after allogeneic hematopoietic stem cell transplantation (a
Externí odkaz:
https://doaj.org/article/b6df4d5250e9414d96aecce10cbf0346
Autor:
Weipeng Liu, Fengdan Huang, Yueting Yao, Yan Liang, Zhiling Yan, Lili Guo, Xinwen Zhang, Li Shi, Yufeng Yao
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundCervical cancer stands as one of the leading causes of cancer-related mortality in women worldwide, yet the precise functions of host genes implicated in its pathogenesis remain elusive. Genome-wide association studies (GWAS) have revealed
Externí odkaz:
https://doaj.org/article/e9f7177181c04b4897c849c36cb8afa5
Autor:
Ming Shi, Jiaojiao Wang, Hongming Huang, Dan Liu, Hai Cheng, Xu Wang, Wei Chen, Zhiling Yan, Wei Sang, Kunming Qi, Depeng Li, Feng Zhu, Zhenyu Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Xiaoming Fei, Weiying Gu, Yuqing Miao, Kailin Xu, Junnian Zheng, Jiang Cao
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Despite the high therapeutic response achieved with B-cell maturation antigen (BCMA)-specific chimeric antigen receptor (CAR) T-cell therapy in relapsed and refractory multiple myeloma (R/R MM), primary resistance and relapse exist with sing
Externí odkaz:
https://doaj.org/article/747a7911739249cd91c5dcffffc31488
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTCervical cancer, among the deadliest cancers affecting women globally, primarily arises from persistent infection with high-risk human papillomavirus (HPV). To effectively combat persistent infection and prevent the progression of precancerou
Externí odkaz:
https://doaj.org/article/c5fcac59691546ddb006a8f86a2ad1b8
Autor:
Huimin Chen, Ruixue Ma, Qianqian Zhang, Fengyi Lu, Yuhan Ma, Jingxin Zhou, Jiang Cao, Kunming Qi, Zhiling Yan, Wei Sang, Feng Zhu, Haiying Sun, Depeng Li, Zhenyu Li, Hai Cheng, Kailin Xu, Wei Chen
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTBackground: Peripheral T-cell lymphomas (PTCL) are an aggressive group of mature T-cell neoplasms, often associated with poor outcomes, in part, due to frequent relapsed/refractory disease. The objective of this study was to assess the progno
Externí odkaz:
https://doaj.org/article/ada56b4285714342bd2679a9915c325d
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0296671 (2024)
Bone marrow-derived CD34-positive (CD34+) endothelial progenitor cells (EPCs) has unique functions in the mechanism of compensatory lung growth (CLG). The content of this study is mainly to describe the effect of microRNA (miR)-155 in the mechanisms
Externí odkaz:
https://doaj.org/article/4e4ed19eed7746f6bc429ea40197eae9
Publikováno v:
Vaccines, Vol 12, Iss 4, p 392 (2024)
Human papillomavirus type 16 (HPV16) infection is responsible for more than 50% of global cervical cancer cases. The development of a vaccine based on cytotoxic T-lymphocyte (CTL) epitopes is a promising strategy for eliminating pre-existing HPV infe
Externí odkaz:
https://doaj.org/article/97511475cc3b4e67a01bfdd25ace768d
Autor:
Yanyan Lu, Hong Zhu, Yang Liu, Ying Wang, Yinxiang Sun, Hai Cheng, Zhiling Yan, Jiang Cao, Wei Sang, Feng Zhu, Depeng Li, Haiying Sun, Junnian Zheng, Kailin Xu, Zhenyu Li
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionChimeric antigen receptor (CAR) T cell therapy has achieved unprecedented efficacy recently. However, the factors related to responses and durable remission are elusive. This study was to investigate the impact of pre-lymphodepletion (pre
Externí odkaz:
https://doaj.org/article/d760ee1cf4614f5e9c0b005c3662d7e8
Autor:
Yang Liu, Xingxing Jie, Li Nian, Ying Wang, Congyue Wang, Jin Ma, Jingjing Jiang, Qingyun Wu, Jianlin Qiao, Wei Chen, Jiang Cao, Zhiling Yan, Ming Shi, Hai Cheng, Feng Zhu, Wei Sang, Depeng Li, Chong Chen, Kailin Xu, Zhenyu Li
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundChimeric antigen receptor - T (CAR-T) cell therapy has shown remarkable efficacy in patients with relapsed/refractory multiple myeloma (R/R MM). However, a subset of patients still experienced progression or relapse, and the predictors of p
Externí odkaz:
https://doaj.org/article/8abb7fa4ee5a4e3e835f5fb6ed6e3fe5
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Cervical carcinoma is one of the most common malignant tumors of the female reproductive system. Lymph nodes metastasis, the most common metastasis, which can be detected even in small-size tumor patients, results in worse prognos
Externí odkaz:
https://doaj.org/article/720996d649f944b1832365daf6909035